BioInfra Co., Ltd. (KOSDAQ:199730)
3,535.00
+95.00 (2.76%)
At close: Mar 6, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 17.20 billion as of March 6, 2026. Its market cap has decreased by -37.87% in one year.
Market Cap
17.20B
Enterprise Value
20.32B
Revenue
21.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,535.00
Market Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 17.20B, a decrease of -87.81%. That is a compound annual growth rate of -50.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 17.20B | -25.26% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curachem | 12.28B |
| SLS BIO | 26.89B |
| Cronex.Co.,Ltd | 9.00B |
| DT&CRO CO. | 36.18B |
| WOOJUNG BIO | 46.03B |
| C&R Research | 47.30B |
| P&K Skin Research Center | 61.52B |
| MEDIZEN HUMANCARE | 3.70B |